This trial is testing a new growth hormone against a current one to see if it's more effective in children with Turner Syndrome, Noonan Syndrome, Idiopathic Short Stature, or who were born small and stay small.
1 Primary · 12 Secondary · Reporting Duration: From screening (visit 1) to visit 15 (week 156)
Active Control
Experimental Treatment
399 Total Participants · 2 Treatment Groups
Primary Treatment: Somapacitan · No Placebo Group · Phase 3
Age 2 - 10 · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: